These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 39212716

  • 21. Defining the Genomic Landscape of Diffuse Sclerosing Papillary Thyroid Carcinoma: Prognostic Implications of RET Fusions.
    Scholfield DW, Fitzgerald CWR, Boe LA, Eagan A, Levyn H, Xu B, Tuttle RM, Fagin JA, Shaha AR, Shah JP, Wong RJ, Patel SG, Ghossein R, Ganly I.
    Ann Surg Oncol; 2024 Sep; 31(9):5525-5536. PubMed ID: 38847983
    [Abstract] [Full Text] [Related]

  • 22. Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma.
    Dinets A, Hulchiy M, Sofiadis A, Ghaderi M, Höög A, Larsson C, Zedenius J.
    Eur J Endocrinol; 2012 Jun; 166(6):1049-60. PubMed ID: 22457234
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Application value of multi-gene mutation detection in the clinical management of pediatric papillary thyroid carcinoma: a preliminary exploration.
    Wang Y, Wang H, Tan G, Wu X, Wang B, Tan Z, Du J, Li X, Xu Y, Yan N, Qian X.
    Front Endocrinol (Lausanne); 2024 Jun; 15():1405142. PubMed ID: 38904052
    [Abstract] [Full Text] [Related]

  • 25. A Performance Comparison of Commonly Used Assays to Detect RET Fusions.
    Yang SR, Aypar U, Rosen EY, Mata DA, Benayed R, Mullaney K, Jayakumaran G, Zhang Y, Frosina D, Drilon A, Ladanyi M, Jungbluth AA, Rekhtman N, Hechtman JF.
    Clin Cancer Res; 2021 Mar 01; 27(5):1316-1328. PubMed ID: 33272981
    [Abstract] [Full Text] [Related]

  • 26. Genomic characterization of high-recurrence risk papillary thyroid carcinoma in a southern Chinese population.
    Li M, Jia H, Qian Q, Wen P, Chen C, Hua Y, Wang K, Zhang W, Shi F.
    Diagn Pathol; 2020 May 11; 15(1):49. PubMed ID: 32393293
    [Abstract] [Full Text] [Related]

  • 27. NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake.
    Lee YA, Lee H, Im SW, Song YS, Oh DY, Kang HJ, Won JK, Jung KC, Kwon D, Chung EJ, Hah JH, Paeng JC, Kim JH, Choi J, Kim OH, Oh JM, Ahn BC, Wirth LJ, Shin CH, Kim JI, Park YJ.
    J Clin Invest; 2021 Sep 15; 131(18):. PubMed ID: 34237031
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinicopathological analysis of thyroid carcinomas with the RET and NTRK fusion genes: characterization for genetic analysis.
    Okubo Y, Toda S, Kadoya M, Sato S, Yoshioka E, Hasegawa C, Ono K, Washimi K, Yokose T, Miyagi Y, Masudo K, Iwasaki H, Hayashi H.
    Virchows Arch; 2024 Sep 15; 485(3):509-518. PubMed ID: 38472412
    [Abstract] [Full Text] [Related]

  • 30. Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins.
    Richardson DS, Gujral TS, Peng S, Asa SL, Mulligan LM.
    Cancer Res; 2009 Jun 01; 69(11):4861-9. PubMed ID: 19487296
    [Abstract] [Full Text] [Related]

  • 31. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
    Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, Basolo F, Demidchik EP, Miccoli P, Pinchera A, Pacini F.
    J Clin Endocrinol Metab; 2001 Jul 01; 86(7):3211-6. PubMed ID: 11443191
    [Abstract] [Full Text] [Related]

  • 32. A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases.
    Hang JF, Chen JY, Kuo PC, Lai HF, Lee TL, Tai SK, Kuo CS, Chen HS, Li WS, Li CF.
    Mod Pathol; 2023 Sep 01; 36(9):100242. PubMed ID: 37307878
    [Abstract] [Full Text] [Related]

  • 33. RET fusion genes in pediatric and adult thyroid carcinomas: cohort characteristics and prognosis.
    Bulanova Pekova B, Sykorova V, Mastnikova K, Vaclavikova E, Moravcova J, Vlcek P, Lancova L, Lastuvka P, Katra R, Bavor P, Kodetova D, Chovanec M, Drozenova J, Matej R, Astl J, Hlozek J, Hrabal P, Vcelak J, Bendlova B.
    Endocr Relat Cancer; 2023 Dec 01; 30(12):. PubMed ID: 37882481
    [Abstract] [Full Text] [Related]

  • 34. A novel RET/PTC variant detected in a pediatric patient with papillary thyroid cancer without ionization history.
    Halkova T, Dvorakova S, Vaclavikova E, Sykorova V, Vcelak J, Sykorova P, Vlcek P, Reboun M, Katra R, Kodetova D, Schrumpf M, van Wezel T, Morreau H, Bendlova B.
    Hum Pathol; 2015 Dec 01; 46(12):1962-9. PubMed ID: 26472164
    [Abstract] [Full Text] [Related]

  • 35. RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease.
    Su X, He C, Ma J, Tang T, Zhang X, Ye Z, Long Y, Shao Q, Shao J, Yang A.
    PLoS One; 2016 Dec 01; 11(11):e0165596. PubMed ID: 27802347
    [Abstract] [Full Text] [Related]

  • 36. BRAF V600E and RET/PTC Promote the Activity of Nuclear Factor-κB, Inflammatory Mediators, and Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Study of 50 Patients in Inner Mongolia.
    Zhou D, Li Z, Bai X.
    Med Sci Monit; 2018 Sep 26; 24():6795-6808. PubMed ID: 30254191
    [Abstract] [Full Text] [Related]

  • 37. ANKRD26-RET - A novel gene fusion involving RET in papillary thyroid carcinoma.
    Staubitz JI, Musholt TJ, Schad A, Springer E, Lang H, Rajalingam K, Roth W, Hartmann N.
    Cancer Genet; 2019 Oct 26; 238():10-17. PubMed ID: 31425920
    [Abstract] [Full Text] [Related]

  • 38. Targeted sequencing of DNA/RNA combined with radiomics predicts lymph node metastasis of papillary thyroid carcinoma.
    Zhang R, Hu L, Cheng Y, Chang L, Dong L, Han L, Yu W, Zhang R, Liu P, Wei X, Yu J.
    Cancer Imaging; 2024 Jun 17; 24(1):75. PubMed ID: 38886866
    [Abstract] [Full Text] [Related]

  • 39. TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort.
    Cruz-Romero SD, González S, Juez JY, Becerra DS, Baldión AM, Hakim JA, González-Devia D, Perdomo S, Rodríguez-Urrego PA.
    Adv Ther; 2024 Feb 17; 41(2):792-805. PubMed ID: 38170436
    [Abstract] [Full Text] [Related]

  • 40. Oncogenic alterations in papillary thyroid cancers of young patients.
    Sassolas G, Hafdi-Nejjari Z, Ferraro A, Decaussin-Petrucci M, Rousset B, Borson-Chazot F, Borbone E, Berger N, Fusco A.
    Thyroid; 2012 Jan 17; 22(1):17-26. PubMed ID: 22150560
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.